Glutamatergic compensatory mechanisms in experimental parkinsonism
- 1 May 1998
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 22 (4) , 609-623
- https://doi.org/10.1016/s0278-5846(98)00030-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Functional architecture of basal ganglia circuits: neural substrates of parallel processingPublished by Elsevier ,2003
- Kinetics of nigral degeneration in a chronic model of MPTP-treated miceNeuroscience Letters, 1997
- A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkeyBrain Research, 1997
- Presymptomatic revelation of experimental ParkinsonismNeuroReport, 1997
- Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatmentMovement Disorders, 1996
- Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot studyEuropean Journal of Pharmacology, 1995
- The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonismJournal of Neurophysiology, 1994
- Subthalamic nucleus modulates burst firing of nigral dopamine neurones via NMDA receptorsNeuroReport, 1994
- Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated MonkeysEuropean Journal of Neuroscience, 1993
- Parkinson's disease: pathophysiologyThe Lancet, 1991